Abstract:Background Congenital heart defects with intractable hypoplasia of the pulmonary arteries without intercourse or with intercourse stenosis is unsuitable for surgical correction or regular palliative procedures. We reported our experience with combined palliative procedures for congenital heart defects with intractable hypoplasia pulmonary arteries. Methods From 2001 to 2012, a total of 41 patients with cyanotic congenital heart defects and intractable hypoplasia of the pulmonary arteries underwent surgical procedures. From among them, 31 patients had pulmonary atresia with ventricular septal defect (VSD) and the other 10 cases had complicated congenital heart defects with pulmonary stenosis. Different kinds of palliative procedures were performed according to the morphology of the right and left pulmonary arteries in every patient. If the pulmonary artery was well developed, a Glenn procedure was performed. A modified Blalock-Taussig shunt or modified Waterston shunt was performed if pulmonary arteries were hypoplastic. If the pulmonary arteries were severely hypoplastic, a Melbourne shunt was performed. Systemic pulmonary artery shunts were performed bilaterally in 25 cases. A systemic-pulmonary shunt was performed on one side and a Glenn procedure was performed contralaterally in 16 cases. Major aortopulmonary collateral arteries were unifocalized in six cases, ligated in two cases and interventionally embolized in two cases. There was one early death because of cardiac arrest and the hospital mortality was 2.4%. Results Five patients suffered from postoperative low cardiac output syndrome, three had perfusion of the lungs, and two pulmonary infections. Systemic pulmonary shunts were repeated after the original operation in three cases due to the occlusion of conduits. The mean follow-up time was 25 months. The pre- and the post-operation left pulmonary indices were (8.13±3.68) vs. (14.9±6.21) mm2/m2. The pre- and post-operation right pulmonary indices were (12.7±8.13) vs. (17.7±7.78) mm2/m2. The pre- and post-operational pulmonary indices were (20.87±9.43) vs. (32.6±11.7) mm2/m2. They were all significantly increased (P <0.001). The diameter of the pulmonary artery increased after the modified Blalock-Taussig shunt ((5.51±0.94) mm2/m2 pre-operation vs. (7.01±1.97) mm2/m2 post-operation), the modified Waterston shunt ((5.70±3.96) mm2/m2 pre-operation vs. (9.17±3.62) mm2/m2 post-operation) and the Melbourne shunt ((2.17±0.41) mm2/m2 pre-operation vs. (7.35±2.49) mm2/m2 post-operation) (all P <0.05). Bilateral pulmonary arteries developed well as compared to their pre-operation development. Hemoglobin decreased from (194±27) to (174±24) g/L (P <0.05) and peripheral oxygen saturation increased from (65±11)% to (84±6)% (P <0.001). During the follow-up of 27 to 49 months, ultimate complete repair was performed in four cases and one patient underwent a Glenn procedure. Conclusions The procedures should be considered on a case to case basis in patients having hypoplasia of the pulmonary arteries with cyanotic congenital heart defects. Combined palliative operations could be an adequate strategic treatment.

The peri-operative observation and mid-long term follow-up of pharmaceutic therapy in the adults of congenital heart disease combined with severe pulmonary hypertension

Long-term postoperative outcome of congenital heart defects with severe pulmonary hypertension in children

Surgical Treatment on Congenital Heart Disease with Severe Pulmonary Hypertension

Clinical study of targeting therapy and transcatheter closure for congenital heart disease with severe ;pulmonary hypertension

Surgical treatment of congenital heart disease combined with severe pulmonary hypertension

A Retrospective Study of Perioperative Risk Factors in 153 Cases of Congenital Heart Disease Associated with Severe Pulmonary Hypertension

Evaluation of the curative effect for unidirectional valve patch repair procedures to congenital heart disease with severe pulmonary hypertension

Clinical research on the postoperative treatment results of congenital heart disease patients with serious pulmonary hypertension

Peri-Operative Pulmonary Hypertension in Paediatric Patients: Current Strategies in Children with Congenital Heart Disease

Characteristics, treatments and survival of pulmonary arterial hypertension associated with congenital heart disease in China: Insights from a national multicenter prospective registry

Impact of Sildenafil Therapy on Pulmonary Arterial Hypertension in Adults with Congenital Heart Disease

One-stop Hybrid Cardiac Surgery for Adults with Complex Heart Disease

Postoperative follow-up of patients with complete atrioventricular septal defect complicated with pulmonary hypertension

Clinical Results of Combined Palliative Procedures for Cyanotic Congenital Heart Defects with Intractable Hypoplasia of Pulmonary Arteries

Effects of treprostinil on pulmonary arterial hypertension during surgery for congenital heart disease complicated with severe pulmonary arterial hypertension

Predictors of operability in children with severe pulmonary hypertension associated with congenital heart disease

Hybrid Approaches under Direct Vision in Management of Multiple Muscular Ventricular Septal Defects with Associated Cardiac Malformations

Surgical Management of Rheumatic Heart Disease with Severe Pulmonary Hypertension

A novel nurse-led, multidisciplinary, and guideline-directed disease intensive management program improves long-term survival of pulmonary hypertension patients

Combined effect of milrinone and NO to treat pulmonary hypertension after cardiopulmonary bypass in congenital heart disease patients

Combined Infusion Via Pulmonary Artery and Aorta in the Effective Weaning from Cardiopulmonary Bypass